Lacosamide Tablet, Film Coated
Product Images NDC 60687-698

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 60687-698). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 mg Lacosamide Tablet Blister (100 mg Blister)

100 mg Lacosamide Tablet Blister (100 mg Blister)
Lacosamide is a pharmaceutical drug available in tablet form with a strength of 100 mg. There is confusion in the provided text, as some sections are incomplete or contain unreadable characters.*
FDA Label Image

100 mg Lacosamide Tablets Carton (100 mg Carton)

100 mg Lacosamide Tablets Carton (100 mg Carton)
This is a description of a medication. The medication is called Lacosamide and is in tablet form. The package contains 60 tablets in total and is only available with a prescription. Each tablet contains 100mg of Lacosamide. The medication should be stored at a temperature between 20°C to 25°C, with excursions permitted between 15°C to 30°C. The medication should be kept out of reach of children and not used if the blister is torn or broken. The medication is distributed by American Health Packaging, located in Curtice, Ohio.*
FDA Label Image

200 mg Lacosamide Tablet Blister (200 mg Blister)

200 mg Lacosamide Tablet Blister (200 mg Blister)
Lacosamide is a medicine, indicated for the adjunctive therapy in the treatment of partial onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older.*
FDA Label Image

200 mg Lacosamide Tablets Carton (200 mg Carton)

200 mg Lacosamide Tablets Carton (200 mg Carton)
Lacosamide is a medication available in the form of tablets containing 200mg each. The usual dosage advice and storage temperature range are given on the packaging. The medication should be kept safe, and out of reach of children. The information on the packaging advises against using the tablets if the outer package is damaged or opened. The manufacturer of the medication is NBC Y87877755 and is distributed by American Health Packaging.*
FDA Label Image

50 mg Lacosamide Tablet Blister (50 mg Blister)

50 mg Lacosamide Tablet Blister (50 mg Blister)
This text appears to be a list of different versions of a medication called Lacosamide, in 50mg doses in tablet form. There are some errors in the text, and it is difficult to determine more information.*
FDA Label Image

50 mg Lacosamide Tablets Carton (50 mg Carton)

50 mg Lacosamide Tablets Carton (50 mg Carton)
This text describes a medication called Lacosamide, which comes in the form of tablets. Each pack contains 60 tablets and is for prescription use only. The medication is meant to be stored at a temperature between 20-25°C and should not be used if the blister is broken. It also provides information on the drug manufacturer and distributor. The text also includes a reference to a PHARMAGIST's suggestion to disperse the medication with the accompanying medication which can benefit the patient.*
FDA Label Image

Figure 1 (Median Percent Reduction in Seizure Frequency per 28 days from Baseline to the Maintenance Phase by Dose)

Figure 1 (Median Percent Reduction in Seizure Frequency per 28 days from Baseline to the Maintenance Phase by Dose)
The text seems to be a table or chart showing the results of different studies involving the use of a medication called Lacosamide compared to a placebo. The percentage figures are related to the dosage used in each study, and there is a note indicating a statistically significant difference between Lacosamide and placebo. The text does not provide further details or context, but it seems to be related to medical research.*
FDA Label Image

Structural Formula (Structure)

FDA Label Image

Figure 2 (Proportion of Patients by Responder Rate for Lacosamide Oral Solution and Placebo Groups in Studies 2, 3, and 4)

Figure 2 (Proportion of Patients by Responder Rate for Lacosamide Oral Solution and Placebo Groups in Studies 2, 3, and 4)
This is a table indicating the Responder Rate for patients taking Placebo and different doses of Lacosamide (200mg/day, 400mg/day, 600mg/day). The Responder Rates are categorized into Improvement, Worsening, and percentages ranging from -100% to 100%. There is no other information available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.